132 related articles for article (PubMed ID: 9767266)
21. Anti-neutrophil-cytoplasmic auto-antibodies (ANCA) in 105 patients (56 adults and 49 children) suffering from cystic fibrosis, attending a Spanish hospital.
Carmona E; Perez-Aguilar F; Lopez JA; Ferrer-Calvete J; Sanchez-Cuenca JM
J Intern Med; 2002 Sep; 252(3):281-2. PubMed ID: 12270011
[No Abstract] [Full Text] [Related]
22. ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associations.
Schultz H; Csernok E; Herlyn K; Reichel PH; Moosig F; Cornely OA; Fagerhol MK; Gross WL
Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S117-20. PubMed ID: 14740437
[TBL] [Abstract][Full Text] [Related]
23. Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis.
Dorlöchter L; Carlsson M; Olafsdottir EJ; Røksund OD; Rosendahl K; Fluge G
J Cyst Fibros; 2004 Aug; 3(3):179-83. PubMed ID: 15463905
[TBL] [Abstract][Full Text] [Related]
24. [Pyoderma gangrenosum associated with anti-proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) induced by propylthiouracil].
Coster A; Dargent JL; de Visscher N; Levecque P; Roquet-Gravy PP
Ann Dermatol Venereol; 2017 May; 144(5):368-373. PubMed ID: 28291538
[TBL] [Abstract][Full Text] [Related]
25. Bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies (ANCA) and associated diseases: clinical relevance of an emerging ANCA target antigen.
Emmi L; Chatzipetrou A
Ann Ital Med Int; 2005; 20(4):205-8. PubMed ID: 16610250
[No Abstract] [Full Text] [Related]
26. Autoantibodies to bactericidal/permeability-increasing protein and cathepsin G in systemic sclerosis.
Grypiotis P; Cozzi F; Ruffatti A
J Rheumatol; 2004 Jul; 31(7):1468-9. PubMed ID: 15229985
[No Abstract] [Full Text] [Related]
27. Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis: two cases and literature review.
Genovese G; Tavecchio S; Berti E; Rongioletti F; Marzano AV
Rheumatol Int; 2018 Jun; 38(6):1139-1151. PubMed ID: 29721696
[TBL] [Abstract][Full Text] [Related]
28. Pyoderma gangrenosum.
Perkins GD; Moudgil H; Jones R
Thorax; 2000 Apr; 55(4):347. PubMed ID: 10766647
[No Abstract] [Full Text] [Related]
29. Target antigen for anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Stoffel MP; Csernok E; Gross WL
Scand J Gastroenterol; 1996 Sep; 31(9):943-4. PubMed ID: 8888446
[No Abstract] [Full Text] [Related]
30. Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy.
Gaffney K; Merry P
Br J Rheumatol; 1996 Dec; 35(12):1327. PubMed ID: 9010068
[No Abstract] [Full Text] [Related]
31. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
32. ANCA defines the clinical disease manifestations of vasculitis.
Zhao MH; Lockwood CM
Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):221-6. PubMed ID: 8946586
[No Abstract] [Full Text] [Related]
33. Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein detected in children with cystic fibrosis inhibit neutrophil-mediated killing of Pseudomonas aeruginosa.
Sedivá A; Bartůnková J; Bartosová J; Jennette C; Falk RJ; Jethwa HS
Microbes Infect; 2003 Jan; 5(1):27-30. PubMed ID: 12593970
[TBL] [Abstract][Full Text] [Related]
34. [Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies)].
Boulenger-Vazel A; Kupfer-Bessaguet I; Gouedard C; Leberre R; Leroy JP; Sonnet E; Desvignes O; Misery L; Sassolas B
Ann Dermatol Venereol; 2005 Jan; 132(1):27-31. PubMed ID: 15746603
[TBL] [Abstract][Full Text] [Related]
35. Granulomatosis with Polyangiitis Presenting with Pyoderma Gangrenosum-Like Ulceration and Negative Cytoplasmic Antineutrophilic Cytoplasmic Antibodies in a Child.
Kass A; Fagan JD; Long P
Pediatr Dermatol; 2017 Sep; 34(5):e231-e234. PubMed ID: 28884919
[TBL] [Abstract][Full Text] [Related]
36. Dermatological presentation of disease associated with antineutrophil cytoplasmic antibodies: a report of two contrasting cases and a review of the literature.
Irvine AD; Bruce IN; Walsh M; Burrows D; Handley J
Br J Dermatol; 1996 May; 134(5):924-8. PubMed ID: 8736337
[TBL] [Abstract][Full Text] [Related]
37. Vasculitis and bronchiectasis in a patient with antibodies to bactericidal/permeability-increasing protein and alpha1-antitrypsin deficiency.
Mahadeva R; Zhao MH; Stewart S; Cary N; Flower C; Lockwood M; Shneerson J
Chest; 1997 Dec; 112(6):1699-701. PubMed ID: 9404779
[TBL] [Abstract][Full Text] [Related]
38. Antineutrophil cytoplasmic antibodies in children.
Sedivá A; Kolárová I; Bartůnková J
Eur J Pediatr; 1998 Dec; 157(12):987-91. PubMed ID: 9877037
[TBL] [Abstract][Full Text] [Related]
39. [Differential diagnosis of "sterile" phlegmonous hand infections].
Daigeler A; Lehnhardt M; Helwing M; Steinstraesser L; Homann HH; Steinau HU; Druecke D
Chirurg; 2006 Nov; 77(11):1040-5. PubMed ID: 16479392
[TBL] [Abstract][Full Text] [Related]
40. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations.
Manolova I; Dancheva M; Halacheva K
Rheumatol Int; 2001 Jul; 20(5):197-204. PubMed ID: 11518040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
